Established in 2006, MiMedx Group designs and develops biomaterial-based products for use in musculoskeletal specialties. The company offers biomaterials to treat a range of acute and chronic diseases and disorders. It serves the health care pharmaceutical markets in Europe, Asia, North America and South America. MiMedx Group utilizes several scientific technologies to develop medical instrumentation and surgical techniques. The company specializes in the commercialization of medical device technologies for application in spine and chronic back pain treatments. It provides products to repair a variety of soft tissues, such as tendons, ligaments and cartilage. In addition, the company offers ongoing product development programs. MiMedx Group is licensed by the University of South Florida Research Foundation for nordihydroguaiaretic acid technologies.